Stocktoria
Dogwood Therapeutics, Inc. DWTX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-12-17
Chart by TradingView
1/9
Piotroski F — financial health
-0.45
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$28.0M | -$12.2M | -$5.4M | -$12.3M | -$15.6M |
| Net income | -$34.3M | -$12.3M | -$5.3M | -$12.2M | -$16.0M |
| Operating cash flow | -$15.6M | -$8.8M | -$4.9M | -$11.5M | -$15.7M |
| Total assets | $90.2M | $94.3M | $4.2M | $8.4M | $15.8M |
| Total liabilities | $15.3M | $30.0M | $358,548 | $1.0M | $1.3M |
| Shareholders' equity | $74.9M | -$10.1M | $3.8M | $7.3M | $14.5M |
| Ratios | |||||
| Return on assets | -38.0% | -13.1% | -127.1% | -146.3% | -101.2% |
| Return on equity | -45.7% | 122.0% | -139.1% | -167.2% | -110.1% |
| Current ratio | 2.76 | 5.21 | 11.62 | 8.02 | 12.37 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -0.45 (distress)
- Working capital / assets 0.06
- Retained earnings / assets -1.199
- EBIT / assets -0.31
- Equity / liabilities 4.903
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001818844 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.